Market Cap
$1.8B
LMAT
LEMAITRE VASCULAR INC
$78.78 ▼ -1.76%
Prev close $80.19Market cap$1.8B
ConsensusBuy
12-mo target$107.00 (+35.8%)
▲ Bullish
Analyst conviction 6/10
Insider Selling Cluster (4 insiders)High Impact Filing (7/10)17 New Institutional Positions20 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on LMAT right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Buy (64%)
Inst. Holders
50 funds
Inst. Value
$1.5B
Inst. Activity
17 buys / 20 sells
SEC Reports
10
Press Releases
1
Price chart 30d -3.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 3, 2026 Insider
Roberts David B was granted 5.287 shares
President and Director
Sep 3, 2026 Insider
Roberts David B was granted 0.345 shares
President and Director
Sep 3, 2026 Insider
Aug 27, 2026 Press Roberts David B was granted 0.306 shares
President and Director
LeMaitre Vascular announced management participation in three upcoming investor conferences. This is a routine investor
Impact 2/10
Aug 27, 2026 announcement
Jul 14, 2026 SEC LeMaitre to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced
LeMaitre Vascular reported Q1 2026 EPS of $0.68, missing consensus of $0.81 by 15.7%, and revenue of $71.5M (in line wit
PRESS-RELEASE — Impact 7/10
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
247,804 shares ($23.8M)
Jun 30, 2026 Inst.
SEI INVESTMENTS CO — ADD
206,764 shares ($19.8M)
Analyst ratings buy % -1.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
64% rate it Buy or better · 14 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 5, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jun 3, 2026 | Barrington Research | MAINTAIN | Outperform | 55% |
| May 6, 2026 | Barrington Research | MAINTAIN | Outperform | 55% |
| May 6, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| May 6, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 4 | 5 | 0 | 0 | 64% | |
| Aug 1, 2026 | 5 | 5 | 5 | 0 | 0 | 67% | |
| Jul 1, 2026 | 5 | 5 | 5 | 0 | 0 | 67% | |
| Jun 1, 2026 | 5 | 5 | 5 | 0 | 0 | 67% | |
| May 1, 2026 | 5 | 6 | 5 | 0 | 0 | 69% | |
| Apr 1, 2026 | 5 | 6 | 5 | 0 | 0 | 69% | |
| Mar 1, 2026 | 5 | 6 | 6 | 0 | 0 | 65% | |
| Feb 1, 2026 | 5 | 6 | 6 | 0 | 0 | 65% |
Price targets
Where 7 covering analysts think LMAT trades over the next 12 months.
$107.00 +35.8% upside Strong Buy
Current$78.78 Low$81.00 Median$100.00 High$132.00 7 analysts
$81.00$132.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 2 bullish, 3 bearish, 0 mixed, 5 neutral · avg impact 4.7/10.Plus 1 press releases.
BEARISHPRESS-RELEASE7/10
LeMaitre Vascular reported Q1 2026 EPS of $0.68, missing consensus of $0.81 by 15.7%, and revenue of
Jul 14, 2026
BEARISHCLUSTER4/10
Three LeMaitre Vascular insiders, including CEO George LeMaitre, sold a total of $3.0M in open-marke
May 11, 2026
NEUTRALCLUSTER2/10
Three insiders at LeMaitre Vascular sold a total of $1.31M in open-market sales within a week of the
May 11, 2026
NEUTRALCLUSTER3/10
Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, follow
May 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 27, 2026
announcement
LeMaitre to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three u
Aug 6, 2026
other
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings
Aug 4, 2026
earnings
LeMaitre Q2 2026 Financial Results
BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, t
Aug 4, 2026
earnings_calendar
LMAT Q2 2026 Earnings Scheduled — 2026-08-04
Jul 23, 2026
earnings_calendar
LMAT Q2 2026 Earnings Scheduled — 2026-07-23
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.69 | $0.68–$0.69 | -8.5% | -1.6% | 0↑ 8↓ | $0.1B | 8 |
| Next Q | $0.78 | $0.77–$0.79 | 14.3% | +0.0% | 1↑ 3↓ | $0.1B | 8 |
| Current FY | $2.88 | $2.84–$2.90 | 14.2% | +0.0% | 0↑ 8↓ | $0.3B | 8 |
| Next FY | $3.18 | $3.04–$3.30 | 10.4% | +0.0% | 0↑ 7↓ | $0.3B | 8 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.686 | — |
| 7d ago | $0.686 | — |
| 30d ago | $0.698 | -0.011 |
| 60d ago | $0.733 | -0.047 |
| 90d ago | $0.733 | -0.047 |
Institutional ownership
Which big funds own LMAT (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.5B total value (15,295,166 shares) as of 2026-Q2. Top holders: BlackRock,, FIRST, CONGRESS. Net selling activity: 20 institutions trimmed/exited vs 17 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 3,272,973 | $314.1M | 21.4% | — |
| FIRST TRUST ADVISORS LP | 1,093,502 | $104.9M | 7.1% | — |
| CONGRESS ASSET MANAGEMENT CO | 963,706 | $92.5M | 6.3% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 953,437 | $91.5M | 6.2% | — |
| STATE STREET CORP | 901,416 | $86.5M | 5.9% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 788,835 | $75.7M | 5.2% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 604,833 | $58.0M | 4.0% | — |
| DIMENSIONAL FUND ADVISORS LP | 493,889 | $47.4M | 3.2% | — |
| GOLDMAN SACHS GROUP INC | 473,194 | $45.4M | 3.1% | — |
| Invesco Ltd. | 448,389 | $43.0M | 2.9% | DOUBLED +188.8% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 41,417 | 247,804 | +498.3% | $23.8M |
| SEI INVESTMENTS CO | ADD | 136,674 | 206,764 | +51.3% | $19.8M |
| Select Equity Group, L.P. | ADD | 100,470 | 181,015 | +80.2% | $17.4M |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 33,147 | 88,915 | +168.2% | $8.5M |
| FEDERATED HERMES, INC. | ADD | 61,427 | 82,468 | +34.3% | $7.9M |
| JPMORGAN CHASE & CO | TRIM | 108,185 | 68,946 | -36.3% | $6.7M |
| Bahl & Gaynor LLC | TRIM | 124,528 | 64,806 | -48.0% | $6.2M |
| Trexquant Investment LP | TRIM | 66,062 | 49,344 | -25.3% | $4.7M |
| CITADEL ADVISORS LLC | TRIM | 97,083 | 42,833 | -55.9% | $4.1M |
| Quantinno Capital Management LP | ADD | 23,298 | 37,690 | +61.8% | $3.6M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 5.287 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 0.345 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 0.306 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 3.576 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 3.157 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 4.352 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 3.632 | — | — |
| Sep 3, 2026 | Roberts David B | President and Director | AWARD | 2.126 | — | — |
| Sep 3, 2026 | Jasinski Lawrence J | Director | AWARD | 1.664 | — | — |
| Sep 3, 2026 | Jasinski Lawrence J | Director | AWARD | 0.885 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for LMAT.
Shares short
1,693,134
Settlement Sep 15, 2026
Change vs prior
+11.3%
Semi-monthly cycle
Days to cover
6.3
At avg daily volume
Of shares outstanding
≈7.4%
Estimate — not % of float
All LMAT filing & press-release reports (11)
- PRESS-RELEASE reportAug 27, 2026
- PRESS-RELEASE reportJul 14, 2026
- CLUSTER reportMay 11, 2026
- CLUSTER reportMay 11, 2026
- CLUSTER reportMay 11, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportApr 14, 2026
- 8-K reportApr 14, 2026
- CLUSTER reportMar 13, 2026
- CLUSTER reportMar 3, 2026
- 8-K reportFeb 25, 2026